772 related articles for article (PubMed ID: 8250662)
1. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S
Cancer J Sci Am; 1995; 1(4):252-60. PubMed ID: 9166485
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin for patients with AIDS treated with zidovudine.
Fischl M; Galpin JE; Levine JD; Groopman JE; Henry DH; Kennedy P; Miles S; Robbins W; Starrett B; Zalusky R
N Engl J Med; 1990 May; 322(21):1488-93. PubMed ID: 2186273
[TBL] [Abstract][Full Text] [Related]
6. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
Marques da Costa R
Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant human erythropoietin in anemia associated with pediatric cancer: study of the identification of predictors of response].
León Molinari P; Jiménez Monteagudo M; Barona Zamora P; Riol Diego M; Castro Paz L; Sierrasesúmaga Ariznavarreta L
An Esp Pediatr; 1998 Jul; 49(1):17-22. PubMed ID: 9718761
[TBL] [Abstract][Full Text] [Related]
8. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
Barlogie B
Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
10. High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study.
Stebler C; Tichelli A; Dazzi H; Gratwohl A; Nissen C; Speck B
Exp Hematol; 1990 Dec; 18(11):1204-8. PubMed ID: 2226680
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery.
Braga M; Gianotti L; Gentilini O; Vignali A; Di Carlo V
Hepatogastroenterology; 1997; 44(15):685-90. PubMed ID: 9222672
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for recombinant human erythropoietin therapy.
Eschbach JW; Adamson JW
Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):2-8. PubMed ID: 2667349
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
[TBL] [Abstract][Full Text] [Related]
14. [Recombinant human erythropoietin in the treatment of anemic patients undergoing chemotherapy for cancer].
Bösze P; Mayer A; Thurzó L; Kiss A; Rák K; Stumpf J
Orv Hetil; 1995 Nov; 136(47):2567-72. PubMed ID: 8532322
[TBL] [Abstract][Full Text] [Related]
15. Monitoring considerations in recombinant human erythropoietin therapy.
Ogden DA
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer.
Henry DH
Semin Hematol; 1993 Oct; 30(4 Suppl 6):12-6. PubMed ID: 8153671
[TBL] [Abstract][Full Text] [Related]
17. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
Sinnassamy P; Andre JL; Treize G; Leroy B
Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus infection, anemia, and survival.
Moore RD
Clin Infect Dis; 1999 Jul; 29(1):44-9. PubMed ID: 10433563
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia.
Revicki DA; Brown RE; Henry DH; McNeill MV; Rios A; Watson T
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):474-84. PubMed ID: 8158542
[TBL] [Abstract][Full Text] [Related]
20. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
Zehnder C; Blumberg A
Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
